SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-09-094642
Filing Date
2009-04-30
Accepted
2009-04-30 17:07:39
Documents
3
Period of Report
2009-06-09
Effectiveness Date
2009-04-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 227664
2 GRAPHIC g58783g26o57.jpg GRAPHIC 19979
3 GRAPHIC g58783g91x42.jpg GRAPHIC 6375
  Complete submission text file 0001193125-09-094642.txt   265751
Mailing Address 220 MIRACLE MILE SUITE 234 CORAL GABLES FL 33134
Business Address 220 MIRACLE MILE SUITE 234 CORAL GABLES FL 33134 (305) 529-2522
Catalyst Pharmaceutical Partners, Inc. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33057 | Film No.: 09784872
SIC: 2834 Pharmaceutical Preparations